This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Food and Drug Administration (FDA) recently enacted a final rule under the Mammography Quality Standards Act ( MQSA ). The Mammography Quality Standards Act (MQSA) was originally enacted in 1992 to ensure high standards in mammography for the detection of breast cancer. What is the? What Does This Mean for Patients?
(R)(M)(ARRT), CRT(M), FSBI, FNCBC Back in the olden days, all patient communication had to go through the patient’s referring physician including biopsy recommendations, ultrasound referrals, additional views and technical repeats, which were almost always related to mammography positioning. She is not happy. You then think, Ugh! By the way.
(R)(M)(ARRT), Breast Imaging Consultant Recent headlines read: “FDA Updates Mammography Regulations in Final MQSA Rule” , “Major Updates Coming to Mammography Quality and Certification Standards….” , “FDA National Reporting Standard”, “Effective date: September 10, 2024”. Why is this quality standard measured and regulated?”
Therefore, it makes sense to have Mammo Techs performing breast ultrasounds, as well as mammograms. These standardized protocols were not developed overnight, but they were accomplished in time with communication, patience and compromise. Selecting the correct individual to maintain quality control is the key to the program's success.
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content